Unorganized› @ Area 52 (US) - Guild Profile
PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective | Molecular Pharmaceutics
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy | Nature Reviews Clinical Oncology
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy - Curry - 2017 - Journal of Cutaneous Pathology - Wiley Online Library
PDF) A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab
Server:Area 52 US | WoWWiki | Fandom
PDF) Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors
Frontiers | TNF-α Inhibitors and Other Biologic Agents for the Treatment of Immune Checkpoint Inhibitor-Induced Myocarditis
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Abstracts from the 38th Annual Meeting of the Histiocyte Society Held Virtually and In Person in Stockholm, Sweden from September 18‐20, 2022 - 2023 - Pediatric Blood & Cancer - Wiley Online Library
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody- Associated Diseases e977 Potential Role of CHI3
Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020–2.12.2020, St.Gallen, Switzerland | SpringerLink
Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy - ScienceDirect
Northern New England Clinical Oncology Society - 2022 Annual Meeting Accepted Abstracts
Frontiers | Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences
Plasmacytic cutaneous pathology: A review - Walsh - 2019 - Journal of Cutaneous Pathology - Wiley Online Library
Cancers | Free Full-Text | Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
Northern New England Clinical Oncology Society - 2022 Annual Meeting Accepted Abstracts
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia | medRxiv
